The molecular diagnostics firm intends to pursue additional disease targets with its AlloMap technology.
The firm signed an agreement for a $15 million credit line and term loans totaling $6 million.
The firm has signed a $500 million credit facility, which it said will be used to provide working capital and fund general corporate purposes.
The firm said there is currently $240 million of borrowings outstanding under the credit facility.
Caliper extended the maturity date on its $25 million credit facility.
CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.
Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.
Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.
In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.